ETHNOBOTANICAL AND ANTIMICROBIAL STUDIES OF SOME PLANTS USED IN KIBWEZI (KENYA) FOR MANAGEMENT OF LOWER RESPIRATORY TRACT INFECTIONS by Kariuki, AC & Njoroge, GN
Kariuki and Njoroge Afr J Tradit Complement Altern Med. (2011) 8(2):144-149 144
ETHNOBOTANICAL AND ANTIMICROBIAL STUDIES OF SOME PLANTS USED IN KIBWEZI
(KENYA) FOR MANAGEMENT OF LOWER RESPIRATORY TRACT INFECTIONS
Kariuki A. C. and Njoroge, G. N.*
Jomo Kenyatta University of Agriculture and Technology




Respiratory tract infections have gained worldwide recognition especially due to the increased incidence of HIV/AIDS.
The bacteria responsible for these infections have also become increasingly resistant to chemotherapeutic agents in lower
respiratory infections in Kibwezi in Kenya. Interviews were conducted using semi-structured questionnaires and detailed
discussions with respondents. During the field surveys direct observations were made on how these plants are used. From the
ethnobotanical survey the modes of preparation used included chewing and boiling. The plant parts used were mostly bark and
root, which implies that the main methods of harvesting these plants are destructive in nature. Water and methanolic extracts of
the three most popular plants, Acacia nilotica, Strychnos heninngsii and Microglossa densiflora were tested against three test
organism: Staphylococcus aureus, Streptococcus pneumoniae and Escherichia coli for their antimicrobial properties. The
efficacy of the extracts was tested by bioassay method using the disk diffusion test. It was interesting to note that none of the
tested water extracts showed any activity against the test organisms. This is despite the fact that about 83% of the local people
used water for extraction. Methanolic extracts of Acacia nilotica and Strychnos heninningsii showed efficacy against S. aureus,
S. pneumoniae and E. coli. The findings of this research indicate that A. nilotica and S. heninngsii have antimicrobial properties
and further work especially using mammalian models is recommended.
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Introduction
Plants have been described as the oldest friends of man due to their value as sources of food, shelter and medicines
(Akerele et al., 1990; Gilan and Rahman, 2005; Rios and Rico, 2005). Estimates show that by the nineteenth century 80% of all
medicines originated from plants (Gilan and Rahman, 2005). The World Health Organization (WHO) has estimated that 80% of
the global population in developing countries depends on traditional medicines mainly from plants (WHO, 2002). In developing
countries there is an increasing attempt to incorporate traditional medicines in local health care systems. Several countries in
Africa have realized the need to develop improved traditional medicines (ITMs) from local plants that are used traditionally for
various ailments (Inngjerdingen et al., 2004). This calls for systematic study of local plants utilization in managing primary
healthcare and antimicrobial trials to authenticate the use of such medicines in various communities. Approximately 25% of all
pharmaceutical products worldwide originated from traditional medicinal knowledge. There is widespread interest in developing
new types of medicinal agents with greater potency and reduced side effects. Higher success rates have been reported when
indigenous knowledge is integrated in the process on bioprospecting activities than using random screening (Carlson, et al., 1997;
Fauci, 1998).
There are many drugs in clinical use today that were discovered from the way plants were used in traditional
communities. Such discoveries include quinine which has been used to manage malaria for many years (van Wyk et al., 2002),
Digitoxin used for heart conditions, Taxol which is used as modern therapy for ovarian cancer (Farnsworth, 1990; Iwu, 1993). So
far two thirds of the global medicinal plants are known to grow in tropical countries (Gasengayire, 2003) and only less than 90
species have been well investigated of their potential.
Traditional medicine is currently the fastest growing medical field with herbal therapies becoming increasingly
popular. This mode of treatment is preferred because it is considered more holistic, acceptable, accessible, low cost and proven to
be safe (Gessler, 1995). Globally, there is an increase in the number of countries regulating the sale of botanical drugs
(ethnoherbals) with current value estimated at US$ 60 billion per annum (Barnes et al., 2002). This global increase in demand
for ethnoherbals is also attributed to dissatisfaction with conventional medicine in terms of effectiveness and/or safety. Further,
there is continued search for novel products from traditional medicinal plants (Makunga et al. 2008) particularly for development
of effective new drugs that are non-toxic and inexpensive (Taylor et al., 2001).
It has been reported that in Kenya for example, about 90% of the population has consented to have used traditional
medicines at least once for various health conditions (Chirchir et al. 2006). In Kenya, the number of patients being treated in
traditional health facilities is on the increase, sometimes reaching well over 500 patients per month attended to by just one
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herbalist (Njoroge, 2006). The Karati Rural Service Center for example, reported an increase in the number of patients from 805
in 1985 to 3726 in 1990 (Githae, 1995). The unresolved question is whether these therapies are effective or not against known
microorganisms. Some studies on some of the East African medicinal plants show that they have activity against known
microorganisms (Okemo, 1996; Fabry et al., 1998).
The knowledge of medicinal plants that may contain bioactive agents lies with the older generation who are slowly
dying with this knowledge leading to the loss of valuable information. This is because the knowledge and the methods of
processing of the crude drugs are only available in the rural communities and only perpetuated by word of mouth and within
families and small communities. Younger people on the other hand who now have taken up formal education rarely get interested
in traditional lifestyles. Much of this knowledge therefore is undocumented and in the verge of being lost. Further, the efficacy of
majority of the herbal medicines have not been tested to authenticate the traditionally claimed role in disease management.
The common respiratory disease in Kenya is pneumonia which is the inflammation of the respiratory tract involving the
lung airways and supporting structures. Pneumonia may be community-acquired (patients are believed to have acquired their
infection outside the hospital setting) or hospital acquired (patients are believed to have acquired their infection within the
hospital setting). Other priority respiratory infections include tuberculosis, whooping cough and diphtheria. H.I.V infected
patients are at high risk of developing pneumonia. Opportunistic infections, (pneumonia being one of them) as a result of severe
immunodeficiency, are a major cause of illness and death among such patients. Some of microorganisms responsible for
respiratory infections include: Streptococcus pneumoniae, Staphylococcus aureu and Escherichia coli. Respiratory tract infection
causing micro-organisms are becoming increasingly resistant to common antibiotics. This has led to the search of novel
antimicrobials from plants, which may present a solution to the problem of resistance.
Strptococcus pneumoniae which is estimated to cause 70% of acute respiratory bacterial infections (Okeke, 2005) is
now known to be the leading cause of respiratory tract related deaths globally especially among young children (Malinoski,
2006). This microorganism is a frequent cause of infections in both the community and hospital but has now acquired increasing
resistance to various antibiotics worldwide (Werthein et al., 2005). Antimicrobial resistance is a global problem but more
pressing in developing countries where infectious disease burden is high and cost constraints restrict the use of newer and more
expensive agents (Okeke, 2005). Bacterial antibiotic resistance has now been detected in more than 100 antibiotics and many
exhibit resistance to multiple agents (Ott and Morris, 2008). This increase in antibiotic resistance has been attributed to
excessive, indiscriminate or inappropriate use of antibiotics in clinical medicine as well as the use of antibiotics as feed additives
to promote growth in livestock (Tambe et al., 2001; Swaffham, 2005). A survey by Union of Concerned Scientist reveals for
example that 70% of all antibiotics in the United States are routinely put in the food and water of healthy animals at the cost of
about 24 million pounds per year (Rossenblatt-Farrell, 2009).
This study aimed at carrying out an ethnobotanical survey in Kibwezi to document medicinal plants used for
respiratory tract infections and test the efficacy of common herbal (aqueous and methanolic) preparations against some
microorganisms known to cause respiratory infections.
Materials and Methods
Study Area
Kibwezi (2°25′S 37°58′E2.42°S 37.97°E) is situated in Makueni District in the Eastern province of Kenya.  The area is 
occupied by the Akamba people who form the fourth largest tribe in Kenya. Traditionally, the Akamba people were semi-
nomadic and possessed large herds of cattle often practicing limited cultivation. They are well known for their knowledge of
medicinal plants and could be one of the groups in Kenya that has best preserved their traditional knowledge on the use of local
plants for medicinal purposes.
Figure 1: Study area showing location of Kibwezi
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Ethnobotanical methodology
Before undertaking the field work, local community leaders were approached so as to help identify people who were
knowledgeable in traditional utilisation of local medicinal plants. Purposeful sampling technique was used as a tool for
identifying key informants familiar with the area and uses of plants. These comprised people who were recommended by
community leaders as knowledgeable in the use of traditional medicinal plants and hence were incorporated in the study as field
guides. Key informants have been used in earlier studies as guides because they are known to be observant and reflective
members of the community who know about the culture and are willing to share their knowledge (Garcia, 2006; Tongco, 2007).
Oral prior-informed consent was sought before interviews were carried. A descriptive research design was used. An interview
guide, consisting of semi-structured questions was used as an instrument for data collection. A pilot test was carried out with a
few respondents to pretest the instrument. Any ambiguous questions were edited before starting the interviews and respondents
who had participated in the pretesting were eliminated in the study. Information on history of respiratory tract infections, plants
used in cases of infection and methods of preparation of the herbal extracts was collected. A total of 30 people were interviewed:
these included traditional healers and local people who use traditional plants for self-medication or treating their family members.
Information gathered included the species used for managing lower respiratory conditions, parts used as well as methods applied
in preparing the crude drugs. Botanical identification was carried out using the relevant taxonomic literature such as local Floras.
Herbarium specimens were collected to act as voucher specimens. These are deposited at the Jomo Kenyatta University
herbarium as a reference collection.
Plant preparation and extraction
The plant parts collected from the field were dried at ambient temperature for 48 hours. The plant parts were then
macerated and ground, and the powder was collected in a clean jar.
i) Methanolic extraction: Twenty grams of the powder from each plant was subjected to extraction using 250ml of solvent,
methanol. This process was conducted for 9 hours for each plant specimen.
The resultant extract was concentrated by evaporation, where 80% of the methanol was removed by heating at 400C and vacuum
suction.
The extracts were then filter sterilized using microbial membrane filters and poured into sterile labeled bijou bottles.
ii) Water extraction: the ground plant material were boiled in 250ml of water in a conical flask, for 2 hours. The mixture was
then sieved using a tea strainer and the filtrate collected into a beaker. Further filtration was conducted with a filter paper, where
the remaining sediments were removed. The final filtrate was filter sterilized and put into sterile labeled bijou bottles.
Reviving of Stock cultures
Stocks of E. coli, S. aureus and S. pneumoniae were revived in media. E. coli and S. aureus were revived in nutrient
broth, while S. pneumoniae was revived in 5% sheep blood agar. All isolates were incubated at 370C for 24 hrs.
 Nutrient Broth:- A liquid basal media that supports growth of nutritionally undemanding micro-organisms. It contains beef
extract and peptone in aqueous solution and sodium chloride (each; 0.5% w/v).
 Blood agar:- This media is used for culturing fastidious micro-organisms, and for detection of hemolysin. It is prepared by
mixing 5-10% of aseptically drawn blood with pre-autoclaved molten agar base and trypticase soy agar.
Bioassay
This is a quantitative procedure in which a given organism is used for assay purposes e.g. measuring concentrations of
anti microbial agents. A single disk diffusion method was used to assess the presence of antimicrobial activities in water and
methanol extracts of the different plants. Whatman’s filter paper was punched, and 6mm disks collected in a beaker. The beaker
was covered with foil paper and autoclaved. The sterile extracts of all plants were serially diluted, using sterile distilled water as a
diluent. The disks were dipped into the dilutions and left to air dry on a clean bench. The revived test organisms were plated onto
Mueller-Hinton agar plates, but S.pneumoniae was plated on Mueller-Hinton enriched with 5% sheep blood. The disks were then
placed at equidistance on all plates, for all extracts. This was done in triplicates. The plates were incubated at 370 C for 24 hrs,
after which results were observed and recorded in tables.
Results and discussion
From the ethbotanical survey it was realized that Acacia nilotica, Strychnos heninningsii and Microglossa densiflora
are the most popular plants in management of respiratory tract infections in Kibwezi (Figure 2).
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Figure 2: Frequency of use of various plant species in managing respiratory tract infections in Kibwezi.
It is important to note that A .nilotica, S. heninngsii and M. densiflora are trees while Clerodendrum myericoides and
Carrisa edulis are shrubs. All these plants occur in semi-arid areas. In Kenya biodiversity in arid and semiarid areas is under
threat due to over-utilization, effects of desertification as well as global warming. In terms of parts utilized in the preparation of
these crude drugs most of them are obtained from roots and barks (Figure 3). Considering the majority of the species used are
trees, this possesses a major threat to their continued availability as these methods of harvesting are destructive. Methods of
raising more populations such as micro-propagation for purposes of sustainable utilization in Kibwezi may be necessary. Local
plant users need to be encouraged to conserve these trees by maintaining them on-farm.
Figure 3: Plant parts utilized in preparation of concoctions for respiratory infections in Kibwezi
None of the tested water extracts of A. nilotica, S. heninngsii and M. densiflora showed any efficacy against S. aureus,
S. pneumoniae or E. coli .It is possible therefore the active ingredients were absent or present in minute quantities and therefore
insignificant amounts. It is also possible that the active ingredients were not water-soluble and therefore could not be extracted in
an aqueous medium. This is interesting data because in 83% of the plant species the local herbalists used boiling (in water) as the
method of extracting the crude drug for managing respiratory tract infections. In development of herbal medicine industry in
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Kenya, it is important to train traditional healers on other potential extracting media as most of them use water as the main
medium.
Methanolic extracts of A. nilotica and S. heninngsii showed efficacy against test organisms S. aureus, S. pneumoniae and E. coli.
The methanolic extract of M. densiflora however did not show any efficacy. Results on antimicrobial activity trials of the extracts
of Acacia nilotica and S. heninngsii against the test organisms, at different concentrations reveal that inhibition zone diameters
decrease with decrease in extract concentrations Table 1). This means that the more concentrated the extract, the higher the
activity against the organism.
Table 1: Levels of activity of extracts against the test microorganisms
Zones of inhibition -E. coli Zones of inhibition- Staphylococcus aureus Zone of inhibition-S. pneumonie
Dilutions of extracts 10 0 10 1 10 2 10 3 10 4 10 5 10 0 10 1 10 2 10 3 10 4 10 5 10 0 10 1 10 2 10 3 10 4 10 5
A. nilotica 10.3 8.66 6.66 0 0 0 11.66 9.33 6.66 0 0 0 8.66 6.66 0 0 0 0
S. henningsii 10.3 8.33 7.33 0 0 0 13 11.33 9.33 0 0 0 9 7.66 0 0 0 0
The minimum inhibitory concentrations for Acacia nilotica were as follows: S.aureus- the lowest dilution that has activity
(M.I.C) is 0.8mg/ml , S. pneumoniae- the lowest dilution that has activity(M.I.C) is 8mg/ml , E.coli- the lowest dilution that has
activity (M.I.C) is 8 x 10-2mg/ml. On the other hand the minimum inhibitory concentrations for Strychnos heninngsii were as
follows: S. aureus- the lowest dilution that has activity (M.I.C) is 0.8mg/ml, S. pneumoniae- the lowest dilution that has activity
(M.I.C) is 8mg/ml, and E .coli- the lowest dilution that has activity ( M.I.C) is 8 x 10-2mg/ml. Methanolic extracts of Strychnos
heninngsii were found to be significantly higher than that of Acacia nilotica (P< 0.005) in regard to S. aureus and S.
pneumoniae. Of the microorganisms used in this trial, S. pneumoniae is known to be resistant to common antibiotics. Considering
the extracts of A. nilotica and S. heninngsii but more so the latter showed activity, these results therefore point to the fact that
these plants hold potential for discovery of antimicrobial agent with success in dealing with the management of pneumonia,
which has become a major killer in Kenya among young children and immuno-compromised individuals. These results are
especially significant because Strptococcus pneumoniae is now known to be the leading cause of respiratory tract related deaths
globally especially among children (Malinoski, 2006). Acute respiratory tract infections are also associated with viral infections
(Williams et al., 2006). It is recommended that the plant extracts from this study be subjected to viruses related to respiratory
diseases. Further work especially involving invitro trials with mammalian models are recommended.
Conclusion
Although the water extracts did not show any antimicrobial activity, the methanolic extracts of A. nilotica and S.
heninngsii showed an inhibitory effect against the three tested micro-organisms S. aureus, S. pneumoniae and E. coli. These
results act as pointers to authenticity of traditional medicinal knowledge of the local people of Kibwezi.
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